DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $855,650 | +3.4% | 3,896 | 0.0% | 0.31% | +5.1% |
| Q2 2023 | $827,729 | -4.7% | 3,896 | +13.0% | 0.29% | -12.0% |
| Q1 2023 | $868,782 | -5.0% | 3,447 | 0.0% | 0.33% | -11.9% |
| Q4 2022 | $914,903 | +2.8% | 3,447 | 0.0% | 0.38% | +0.8% |
| Q3 2022 | $890,000 | +1.8% | 3,447 | 0.0% | 0.38% | -0.5% |
| Q2 2022 | $874,000 | -13.6% | 3,447 | 0.0% | 0.38% | +6.2% |
| Q1 2022 | $1,011,000 | -10.3% | 3,447 | +0.7% | 0.36% | -3.8% |
| Q4 2021 | $1,127,000 | +10.6% | 3,424 | +2.3% | 0.37% | +5.4% |
| Q3 2021 | $1,019,000 | +13.5% | 3,347 | 0.0% | 0.35% | +17.8% |
| Q2 2021 | $898,000 | +23.9% | 3,347 | +3.9% | 0.30% | +11.2% |
| Q1 2021 | $725,000 | -2.3% | 3,221 | -3.6% | 0.27% | -8.6% |
| Q4 2020 | $742,000 | +3.2% | 3,340 | 0.0% | 0.29% | -14.1% |
| Q3 2020 | $719,000 | +21.2% | 3,340 | -0.4% | 0.34% | +16.0% |
| Q2 2020 | $593,000 | +27.8% | 3,355 | 0.0% | 0.29% | -1.0% |
| Q1 2020 | $464,000 | -15.5% | 3,355 | -6.3% | 0.30% | +12.5% |
| Q4 2019 | $549,000 | +6.2% | 3,579 | 0.0% | 0.26% | +2.7% |
| Q3 2019 | $517,000 | +1.0% | 3,579 | 0.0% | 0.26% | -8.6% |
| Q2 2019 | $512,000 | +8.5% | 3,579 | 0.0% | 0.28% | +11.1% |
| Q1 2019 | $472,000 | +26.9% | 3,579 | -0.8% | 0.25% | +5.0% |
| Q4 2018 | $372,000 | -0.3% | 3,607 | +5.0% | 0.24% | +21.8% |
| Q3 2018 | $373,000 | +10.0% | 3,436 | 0.0% | 0.20% | +7.7% |
| Q2 2018 | $339,000 | +0.9% | 3,436 | 0.0% | 0.18% | -2.1% |
| Q1 2018 | $336,000 | +5.3% | 3,436 | 0.0% | 0.19% | +9.4% |
| Q4 2017 | $319,000 | +8.1% | 3,436 | 0.0% | 0.17% | -7.6% |
| Q3 2017 | $295,000 | +1.7% | 3,436 | 0.0% | 0.18% | -11.9% |
| Q2 2017 | $290,000 | -1.4% | 3,436 | 0.0% | 0.21% | -10.3% |
| Q1 2017 | $294,000 | +10.1% | 3,436 | 0.0% | 0.23% | -8.6% |
| Q4 2016 | $267,000 | +5.1% | 3,436 | +6.2% | 0.26% | +9.9% |
| Q3 2016 | $254,000 | -22.3% | 3,236 | 0.0% | 0.23% | -27.2% |
| Q2 2016 | $327,000 | +6.5% | 3,236 | 0.0% | 0.32% | +2.9% |
| Q1 2016 | $307,000 | +2.0% | 3,236 | 0.0% | 0.31% | +21.0% |
| Q4 2015 | $301,000 | +9.1% | 3,236 | 0.0% | 0.26% | +6.2% |
| Q3 2015 | $276,000 | +6.2% | 3,236 | +6.6% | 0.24% | +18.6% |
| Q2 2015 | $260,000 | +0.8% | 3,036 | 0.0% | 0.20% | -3.8% |
| Q1 2015 | $258,000 | -0.8% | 3,036 | 0.0% | 0.21% | -4.1% |
| Q4 2014 | $260,000 | +12.6% | 3,036 | 0.0% | 0.22% | +11.1% |
| Q3 2014 | $231,000 | -3.3% | 3,036 | 0.0% | 0.20% | +0.5% |
| Q2 2014 | $239,000 | +4.8% | 3,036 | 0.0% | 0.20% | -6.2% |
| Q1 2014 | $228,000 | -14.0% | 3,036 | -11.6% | 0.21% | +19.9% |
| Q4 2013 | $265,000 | – | 3,436 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |